2,3-bis(3'-hydroxybenzyl)butyrolactone
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
Line 27: | Line 27: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
+ | ==Description== | ||
+ | lignan isolated from urine of humans and other mammals; RN given refers to cpd without isomeric designation; structure given in second source |
Revision as of 09:06, 19 February 2009
2,3-bis(3'-hydroxybenzyl)butyrolactone
| |
Systematic (IUPAC) name | |
3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C18H18O4 |
Mol. mass | 298.33 |
SMILES | & |
Synonyms | Enterolactone |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Description
lignan isolated from urine of humans and other mammals; RN given refers to cpd without isomeric designation; structure given in second source